Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt No Debt
PURE's Cash to Debt is ranked higher than
100% of the 1000 Companies
in the Global Chemicals industry.

( Industry Median: 0.60 vs. PURE: No Debt )
Ranked among companies with meaningful Cash to Debt only.
PURE' s 10-Year Cash to Debt Range
Min: 0.01  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.82
PURE's Equity to Asset is ranked higher than
91% of the 858 Companies
in the Global Chemicals industry.

( Industry Median: 0.53 vs. PURE: 0.82 )
Ranked among companies with meaningful Equity to Asset only.
PURE' s 10-Year Equity to Asset Range
Min: -0.48  Med: 0.82 Max: 0.98
Current: 0.82
-0.48
0.98
Interest Coverage No Debt
PURE's Interest Coverage is ranked higher than
99% of the 561 Companies
in the Global Chemicals industry.

( Industry Median: 47.01 vs. PURE: No Debt )
Ranked among companies with meaningful Interest Coverage only.
PURE' s 10-Year Interest Coverage Range
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 5
Z-Score: -12.06
M-Score: -4.44
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -1334.02
PURE's Operating margin (%) is ranked lower than
99% of the 986 Companies
in the Global Chemicals industry.

( Industry Median: 5.20 vs. PURE: -1334.02 )
Ranked among companies with meaningful Operating margin (%) only.
PURE' s 10-Year Operating margin (%) Range
Min: -3094.83  Med: -895.00 Max: 8.82
Current: -1334.02
-3094.83
8.82
Net-margin (%) -1334.81
PURE's Net-margin (%) is ranked lower than
99% of the 987 Companies
in the Global Chemicals industry.

( Industry Median: 3.67 vs. PURE: -1334.81 )
Ranked among companies with meaningful Net-margin (%) only.
PURE' s 10-Year Net-margin (%) Range
Min: -2831.03  Med: -470.75 Max: 544.87
Current: -1334.81
-2831.03
544.87
ROE (%) -269.33
PURE's ROE (%) is ranked lower than
99% of the 974 Companies
in the Global Chemicals industry.

( Industry Median: 6.96 vs. PURE: -269.33 )
Ranked among companies with meaningful ROE (%) only.
PURE' s 10-Year ROE (%) Range
Min: -353.83  Med: -80.25 Max: 31.51
Current: -269.33
-353.83
31.51
ROA (%) -199.46
PURE's ROA (%) is ranked lower than
99% of the 1009 Companies
in the Global Chemicals industry.

( Industry Median: 3.53 vs. PURE: -199.46 )
Ranked among companies with meaningful ROA (%) only.
PURE' s 10-Year ROA (%) Range
Min: -563.63  Med: -68.95 Max: 19.33
Current: -199.46
-563.63
19.33
ROC (Joel Greenblatt) (%) -14387.37
PURE's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the 1003 Companies
in the Global Chemicals industry.

( Industry Median: 9.79 vs. PURE: -14387.37 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PURE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -13079.12  Med: -622.53 Max: 17.14
Current: -14387.37
-13079.12
17.14
Revenue Growth (3Y)(%) -41.50
PURE's Revenue Growth (3Y)(%) is ranked lower than
97% of the 787 Companies
in the Global Chemicals industry.

( Industry Median: 3.90 vs. PURE: -41.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PURE' s 10-Year Revenue Growth (3Y)(%) Range
Min: -71.2  Med: -8.45 Max: 75.2
Current: -41.5
-71.2
75.2
EBITDA Growth (3Y)(%) -35.20
PURE's EBITDA Growth (3Y)(%) is ranked lower than
95% of the 697 Companies
in the Global Chemicals industry.

( Industry Median: 2.10 vs. PURE: -35.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PURE' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -35.2  Med: -4.80 Max: 11.6
Current: -35.2
-35.2
11.6
EPS Growth (3Y)(%) -37.80
PURE's EPS Growth (3Y)(%) is ranked lower than
91% of the 629 Companies
in the Global Chemicals industry.

( Industry Median: 3.60 vs. PURE: -37.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PURE' s 10-Year EPS Growth (3Y)(%) Range
Min: -37.8  Med: -5.20 Max: 8.1
Current: -37.8
-37.8
8.1
» PURE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with PURE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 8.89
PURE's P/B is ranked lower than
93% of the 952 Companies
in the Global Chemicals industry.

( Industry Median: 1.67 vs. PURE: 8.89 )
Ranked among companies with meaningful P/B only.
PURE' s 10-Year P/B Range
Min: 2.26  Med: 9.01 Max: 149
Current: 8.89
2.26
149
P/S 71.00
PURE's P/S is ranked lower than
99% of the 978 Companies
in the Global Chemicals industry.

( Industry Median: 1.06 vs. PURE: 71.00 )
Ranked among companies with meaningful P/S only.
PURE' s 10-Year P/S Range
Min: 4.97  Med: 60.49 Max: 520
Current: 71
4.97
520
Current Ratio 3.74
PURE's Current Ratio is ranked higher than
86% of the 869 Companies
in the Global Chemicals industry.

( Industry Median: 1.74 vs. PURE: 3.74 )
Ranked among companies with meaningful Current Ratio only.
PURE' s 10-Year Current Ratio Range
Min: 0.15  Med: 2.63 Max: 31.59
Current: 3.74
0.15
31.59
Quick Ratio 3.47
PURE's Quick Ratio is ranked higher than
91% of the 869 Companies
in the Global Chemicals industry.

( Industry Median: 1.19 vs. PURE: 3.47 )
Ranked among companies with meaningful Quick Ratio only.
PURE' s 10-Year Quick Ratio Range
Min: 0.06  Med: 1.77 Max: 30.75
Current: 3.47
0.06
30.75
Days Inventory 219.00
PURE's Days Inventory is ranked lower than
95% of the 963 Companies
in the Global Chemicals industry.

( Industry Median: 65.59 vs. PURE: 219.00 )
Ranked among companies with meaningful Days Inventory only.
PURE' s 10-Year Days Inventory Range
Min: 30.42  Med: 335.93 Max: 2247.12
Current: 219
30.42
2247.12
Days Sales Outstanding 49.67
PURE's Days Sales Outstanding is ranked higher than
62% of the 826 Companies
in the Global Chemicals industry.

( Industry Median: 58.66 vs. PURE: 49.67 )
Ranked among companies with meaningful Days Sales Outstanding only.
PURE' s 10-Year Days Sales Outstanding Range
Min: 8.01  Med: 85.88 Max: 516.03
Current: 49.67
8.01
516.03

Valuation & Return

vs
industry
vs
history
Price/Net Cash 17.75
PURE's Price/Net Cash is ranked lower than
67% of the 93 Companies
in the Global Chemicals industry.

( Industry Median: 10.50 vs. PURE: 17.75 )
Ranked among companies with meaningful Price/Net Cash only.
PURE' s 10-Year Price/Net Cash Range
Min: 1.95  Med: 21.87 Max: 328
Current: 17.75
1.95
328
Price/Net Current Asset Value 14.20
PURE's Price/Net Current Asset Value is ranked lower than
73% of the 395 Companies
in the Global Chemicals industry.

( Industry Median: 5.72 vs. PURE: 14.20 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
PURE' s 10-Year Price/Net Current Asset Value Range
Min: 1.85  Med: 15.44 Max: 356
Current: 14.2
1.85
356
Price/Tangible Book 14.20
PURE's Price/Tangible Book is ranked lower than
96% of the 910 Companies
in the Global Chemicals industry.

( Industry Median: 1.75 vs. PURE: 14.20 )
Ranked among companies with meaningful Price/Tangible Book only.
PURE' s 10-Year Price/Tangible Book Range
Min: 1.21  Med: 10.42 Max: 266.67
Current: 14.2
1.21
266.67
Price/Median PS Value 1.18
PURE's Price/Median PS Value is ranked higher than
52% of the 905 Companies
in the Global Chemicals industry.

( Industry Median: 1.22 vs. PURE: 1.18 )
Ranked among companies with meaningful Price/Median PS Value only.
PURE' s 10-Year Price/Median PS Value Range
Min: 0.02  Med: 0.46 Max: 8.16
Current: 1.18
0.02
8.16
Earnings Yield (Greenblatt) (%) -31.69
PURE's Earnings Yield (Greenblatt) (%) is ranked lower than
97% of the 988 Companies
in the Global Chemicals industry.

( Industry Median: 4.40 vs. PURE: -31.69 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PURE' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -57.3  Med: 0.00 Max: 0
Current: -31.69
-57.3
0

Business Description

Industry: Chemicals » Chemicals
Compare:BASFY, DD, SHECY, URALL, APD » details
Pure Bioscience Inc was incorporated in the state of California on August 24, 1992. It has initial public offering in August 1996. The Company is engaged in the discovery, development and commercialization of bioscience products that provide solutions to health challenges. Its technology platform is based on stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial. The Company manufactures and sells SDC-based disinfecting and sanitizing products, which are registered by the Environmental Protection Agency, or EPA, to distributors and end users. It also manufactures and sells various SDC-based formulations to manufacturers for use as a raw material in the production of personal care and other products. The foundation of its technology platform is a proprietary electrochemical process that allows it to generate ionized silver in the presence of organic acid. This process creates a solution containing stabilized ionic silver that can function as an antimicrobial. The Companys current products all contain SDC, which is produced by ionizing silver in citric acid. SDC is non-toxic, non-caustic, colorless, odorless and formulates well with other compounds. The Company believes that SDC is distinguished from other products in the marketplace because of its superior efficacy and toxicity profiles. The Companys manufacture and package its disinfectant and sanitizing products as well as various raw material formulations at its corporate headquarters in El Cajon, California. The Companys business is subject to various government regulations relating to the protection of public health and the environment.
» More Articles for PURE

Headlines

Articles On GuruFocus.com
PURE Bioscience to Present at the 2nd Annual Growth Capital Expo on April 13th Apr 09 2015 
PURE(R) Hard Surface Disinfectant Remediates Listeria Contamination in Shuttered Food Processing Fac Dec 10 2014 
PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014 Dec 02 2014 
PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With S Nov 12 2014 
PURE Withdraws Food Contact Notification for SDC Antimicrobial Use in Raw Poultry Processing Nov 10 2014 
PURE Bioscience Names Tom Y. Lee, CPA, as Sixth Member of Its Board of Directors Oct 27 2014 
PURE Bioscience Hosts Year-End Results Conference Call October 28, 2014 to Review Progress of SDC An Oct 20 2014 
PURE Hard Surface Disinfectant Now Available for Use in Subway(R) Restaurants Nationwide Oct 17 2014 
PURE Submits Food Contact Notification to FDA for SDC Antimicrobial Use in Produce Processing Oct 15 2014 
PURE Bioscience Reports Operating Results (10-Q) Mar 17 2011 

More From Other Websites
PURE BIOSCIENCE, INC. Financials Jun 17 2015
PURE Resubmits Food Contact Notification to FDA for SDC Antimicrobial Use in Raw Poultry Processing Jun 17 2015
PURE Resubmits Food Contact Notification to FDA for SDC Antimicrobial Use in Raw Poultry Processing Jun 17 2015
Edited Transcript of PURE earnings conference call or presentation 11-Jun-15 8:30pm GMT Jun 15 2015
10-Q for PURE Bioscience, Inc. Jun 13 2015
PURE Exited Fiscal Third Quarter With a Strong Balance Sheet Jun 12 2015
PURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jun 11 2015
PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results Jun 11 2015
PURE Bioscience to Present at the 2015 Impact Investor Conference on June 19th Jun 10 2015
PURE Bioscience to Present at the 2015 Impact Investor Conference on June 19th Jun 10 2015
PURE BIOSCIENCE HOSTS FISCAL Q3 RESULTS CONFERENCE CALL JUNE 11, 2015 TO REVIEW PROGRESS OF... Jun 04 2015
PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of... Jun 04 2015
PURE Bioscience Prepares to Resubmit Food Contact Notification with FDA for SDC Antimicrobial Use in... Jun 03 2015
PURE Bioscience Prepares to Resubmit Food Contact Notification With FDA for SDC Antimicrobial Use in... Jun 03 2015
PURE Bioscience to Present at the 2015 Marcum MicroCap Conference on May 28th May 26 2015
PURE Bioscience to Present at the 2015 Marcum MicroCap Conference on May 28th May 18 2015
PURE Bioscience to Present at the 2nd Annual Growth Capital Expo on April 13th Apr 10 2015
PURE Bioscience to Present at the 2nd Annual Growth Capital Expo on April 13th Apr 09 2015
PURE Bioscience Reports 2015 Fiscal Second Quarter and Six-Month Financial Results Mar 11 2015
PURE Reports Strong Fiscal Second Quarter Financial Results of 2015 Mar 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK